Limited data were published on the management of direct oral anticoagulants in the insertion of pacemaker and cardiac monitoring devices. This study describes the management and outcomes of edoxaban, a direct oral factor Xa inhibitor, in patients undergoing pacemaker or monitoring device implantation in routine clinical practice.

中文翻译：

---

使用起搏器和心脏监测程序的依度沙班患者的血栓栓塞和出血风险：全球 EMIT 项目的结果

关于直接口服抗凝剂插入起搏器和心脏监测设备的管理数据有限。本研究描述了依多沙班（一种直接口服 Xa 因子抑制剂）在常规临床实践中接受起搏器或监测装置植入的患者的管理和结果。